SpliceBio News and Activities

Acquisition, funding and merger involving SpliceBio.

• SpliceBio has just announced a $135 Million fundraising (posted on June 11 2025).

View the org chart displaying its 28 main executives

Most searched biographies at SpliceBio

• Miquel Vila-Perelló, Director and Chief Executive Officer
• Daniela Begolo, Director
• Erica Whittaker, Director

Popular executive movements at SpliceBio

• John Tobin who was Vice President, Clinical Operations, becomes Senior Vice President, Clinical Operations  (posted on May 20 2026).
• Don Munoz has joined the company as Chief Financial Officer  (posted on January 8 2026).

Create your alert
to follow the executive moves at SpliceBio.

SpliceBio has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by SpliceBio

• News - Splice Bio

Social media about SpliceBio

• SpliceBio on Wikipedia, Google News & Yahoo Finance
• SpliceBio on LinkedIn, X (Twitter) & YouTube